TypeName: Business Offer
Country: United States
Summary: Ixabepilone (also known as azaepothilone B, or BMS-247550) is an orally bioavailable microtubule inhibitor. Ixabepilone was a semisynthetic analogue of epothilone B with antineoplastic activity. Ixabepilone binds to tubulin and promotes tubulin polymerization and microtubule stabilization, thereby arresting cells in the G2-M phase of the cell cycle and inducing tumor cell apoptosis. This agent demonstrates antineoplastic activity against taxane-resistant cell lines. Ixabepilone was approved in 2007.https://www.bocsci.com/ixabepilone-cas-219989-84-1-item-63099.html
Description: [RequestDescription]
OfferId: 2376
Name:Alex Brown
Telphone: